Navigation Links
Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
Date:12/6/2011

DANBURY, Conn., Dec. 6, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the fourth quarter ended September 30, 2011.

Fourth Quarter Operating Highlights

During Biodel's fourth quarter of fiscal year 2011, the company:

  • Selected a new lead candidate formulation of ultra-rapid-acting recombinant human insulin, or RHI, for a Phase 1 clinical trial;
  • Extended an agreement with a pharmaceutical company for the supply of an insulin analog as the active pharmaceutical ingredient, or API, to be used in the clinical development of ultra-rapid-acting insulin candidates;
  • Continued pipeline development with advances in liquid stabilized glucagon program; and
  • Conserved cash by instituting cost cutting measures to maintain cash runway through the second calendar quarter of 2013.

  • Dr. Errol De Souza, president and chief executive officer of Biodel, stated:  "The focus and execution of our team has allowed us to rapidly advance a new ultra-rapid-acting recombinant human insulin formulation, which will be in the clinic next quarter. Furthermore, we are encouraged by having secured insulin analog supply for our clinical program.   The goal of the new formulations is to mimic the pharmacokinetic and pharmacodynamic profiles seen in Linjeta™ while improving tolerability.  Continued focus and prudent use of resources will allow us to develop a new generation of ultra-rapid-acting insulin product candidates, leverage other promising candidates in our pipeline and build value for shareholders."

    Fourth Quarter Financial Results

    Biodel reported a net profit of $4.1 million, or basic earnings per share of $0.11 or a diluted earnings per share of $0.10, which includes an $8.7 million decrease in warrant liability for the quarter ended September 30, 2011, compared to a net lo
    '/>"/>

    SOURCE Biodel Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Biodel Announces Name Change for Lead Product Candidate
    2. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
    3. Biodel to Raise $30 Million Through Registered Direct Offering
    4. BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study
    5. Biodel Reports Third Quarter Fiscal Year 2011 Financial Results
    6. BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain
    7. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    8. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    9. Par Pharmaceutical Reports Second Quarter 2008 Results
    10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    11. Pharmos Corporation Reports 2008 Second Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... 2015 Roka Bioscience, Inc. (NASDAQ: ROKA ), ... for the detection of foodborne pathogens,  today announced that ... America Merrill Lynch 2015 Health Care Conference on May 12 ... at the Wynn, Las Vegas NV. ... be available through the investor relations section of Roka Bioscience,s ...
    (Date:5/5/2015)... 2015 VetStem Biopharma, proudly announces ... Jeffrey Schaffer, DVM, as Director of Veterinary Professional ... of experience in the veterinary regenerative medicine field ... our veterinarian lead organization”. Dr. Alexis Nahama, ... will be responsible for all technical activities in ...
    (Date:5/5/2015)... , May 05, 2015 Research ... has announced the addition of the ... to their offering. Macromolecules which ... undergo separation or are broken into smaller ... products. This separation requires various advanced systems ...
    (Date:5/5/2015)... TEL AVIV, Israel , May 5, 2015 ... that the Company was approved to continue trading ... companies. OTCQB Marketplace allows for ... an electronic broker-dealers. Investors can have real-time quotes ... The OTCQB Marketplace includes ...
    Breaking Biology Technology:Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2
    ... (Nasdaq: QGLY ) today reported net sales from ... June 30, 2008,compared to $2.2 million reported for the ... ended June 30, 2008, net sales were $7.4 million,compared ... June 30, 2007., 2008 net sales were influenced ...
    ... have devised a way to squeeze light into tighter ... new technology in the fields of optical communications, miniature ... in passing light through gaps 200 nanometers wide, about ... hair. A group of UC Berkeley researchers led by ...
    ... July 30 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC ... the leading plasma-based pharmaceutical companies in the,People,s Republic ... 2008, it has appointed Mr. Sean Shao, Dr. ... independent members of its Board of Directors, and ...
    Cached Biology Technology:The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 4The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 5The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 6New technique to compress light could open doors for optical communications 2New technique to compress light could open doors for optical communications 3China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 2China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 3China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 4
    (Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
    (Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
    (Date:4/2/2015)... 2, 2015 At its 2015 ACMG Annual ... , the American College of Medical Genetics and ... to its Board.  Members of the ACMG Board of ... forming and advancing its policies and programs. ACMG is ... "It,s an eventful time in medical genetics and ...
    Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
    ... F.L. MARCH 27, 2009 The founder of a ... genetic tests in making medical decisions is the 2009 ... for lifetime achievement in the field of genetic sciences. ... the University of Washington School of Medicine in Seattle, ...
    ... Scripps Research Institute has obtained the first glimpse of a ... cells. The protein, called P-glycoprotein or P-gp for short, is ... chemotherapy drugs. Understanding its structure may help scientists design more ... March 27, 2009, issue of the journal Science . ...
    ... new drug developed at the University of California, Davis ... II of human clinical trials to evaluate its efficacy. ... (s-EH) inhibitor, is "a first-in-class drug which may treat ... entomologist Bruce Hammock, who with UC Berkeley cell biologist ...
    Cached Biology News:Roberta A. Pagon receives lifetime award in genetics from March of Dimes 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5
    Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
    ... The Bio-Plex maintenance, calibration, and ... a custom 96-well plate used ... and calibration procedures using the ... MCV plate is for use ...
    ... is the first biological reagent ... them, and not just by ... only anti-mycoplasma agent that can ... stocks directly. The cytotoxicity of ...
    A component of the Acridinium protein labeling kit....
    Biology Products: